NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/06/2026
Voltar para busca
Dado oficial do USPTO
UNIVERSAL ASSEMBLY PLATFORM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
UNIVERSAL ASSEMBLY PLATFORM
ST13
US500000079416426Classe
1, 5, 42
Pedido
79416426
Registro
8299591
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
16/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
20/12/2024
Data de registro
16/06/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/06/2026
Última transação
16/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
US
Examinador
BELL,JUNA QUEEN
Unidade examinadora
O60
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Valink Therapeutics Inc.
Representantes
Matthew A. Homyk Blank Rome LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industry and science; proteins for use in science; proteins for use in industry; proteins for detecting antibodiesother than for medical use; proteins for binding antibodiesother than for medical use; immunological antibodiesother than for medical use; biological preparations for use in industry and science; chemical preparations for use in the biotechnological industry; chemicals for use in the pharmaceutical industry; chemical preparations for use in the production of drugs; chemicals for use in scientific researchother than medical or veterinary purposes; chemicals for use in biotechnological product development
Classe 5
Pharmaceuticals and medical preparations for the prevention and treatment of cancer in humans and animals; pharmaceutical drugs for the prevention and treatment of cancer in humans and animals; pharmaceutical preparations for the prevention and treatment of cancer in humans and animals; antibodies for medical purposes; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; anti-cancer drugs; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of tumours; chemotherapeutics; biotechnological preparations for medical use for the treatment of cancer
Classe 42
Scientific and technological servicesresearch and design relating thereto in the fields of pharmaceuticalbiomedicalchemical sciences; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research and development for the pharmaceutical industry; scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical products; testing of pharmaceuticals; biochemistry drug servicespharmaceutical drug development services; biotechnology research; biological researchclinical research in the field of radiology and chemotherapy and medical research; research and development in the field of vaccines and medicines; scientific research for medical purposes in the area of cancerous diseases; research and development services in the field of antibodies; research and development in the pharmaceutical and biotechnology fields; biotechnology researchbiotechnology testing; scientific research relating to biotechnology; biochemistry consultancy; biochemistry research services; biochemical research and development; research and development in the field of biotechnology; biochemical engineering services; veterinary research laboratory services; medical research laboratory services; medical research laboratory services relating to pharmaceuticals; providing information relating to scientific research in the fields of biochemistry and biotechnology; consultancy in the field of pharmaceutical research; scientific consultancy in the field of biotechnology; consultancy relating to research and development in the field of therapeutics
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
16/06/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/04/2026
PUBO
PUBLISHED FOR OPPOSITION
28/04/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/04/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/03/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/03/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/03/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/12/2025
GNRT
NON-FINAL ACTION E-MAILED
02/12/2025
CNRT
NON-FINAL ACTION WRITTEN
02/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/11/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/11/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/11/2025
RFNT
REFUSAL PROCESSED BY IB
23/08/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/08/2025
RFRR
REFUSAL PROCESSED BY MPU
02/08/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/07/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/06/2025
CNRT
NON-FINAL ACTION WRITTEN
12/06/2025
DOCK
ASSIGNED TO EXAMINER
06/06/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
16/05/2025
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
09/05/2025
MAFR
APPLICATION FILING RECEIPT MAILED
07/02/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/02/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/02/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace UNIVERSAL ASSEMBLY PLATFORM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.